Abstract
We determined the antimicrobial susceptibility of 90 clinical isolates of Stenotrophomonas maltophilia collected in 2009 at a tertiary care hospital in Korea. Trimethoprim-sulfamethoxazole, minocycline, and levofloxacin were active against most of the isolates tested. Moxifloxacin and tigecycline were also active and hold promise as therapeutic options for S. maltophilia infections.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-Infective Agents / pharmacology*
-
Hospitals
-
Korea
-
Levofloxacin
-
Microbial Sensitivity Tests
-
Minocycline / pharmacology
-
Ofloxacin / pharmacology
-
Stenotrophomonas maltophilia / drug effects*
-
Trimethoprim, Sulfamethoxazole Drug Combination / pharmacology
Substances
-
Anti-Infective Agents
-
Levofloxacin
-
Trimethoprim, Sulfamethoxazole Drug Combination
-
Ofloxacin
-
Minocycline